|

Pelareorep Clinical Trials

1 actively recruiting trial

Pipeline

Phase 1/2: 1

Top Sponsors

  • Oncolytics Biotech1

Indications

  • Squamous Cell Carcinoma of the Anus Stage Unspecified1
  • Anal Cancer Metastatic1
  • Unresectable Pancreatic Carcinoma1
  • Pancreatic Cancer Metastatic1
  • Cancer1

Other1 trial

A Study in Advanced or Metastatic Gastrointestinal Cancers Exploring Treatment Combinations With Pelareorep and Atezolizumab
Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.